Amneal Pharmaceuticals, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $3.61B | $3.50B | $110.6M |
| FY2025 | $3.75B | $3.68B | $282.0M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $3.61B | $3.50B | $110.6M |
| FY2025 | $3.75B | $3.68B | $282.0M |